LUCD
LUCD
NASDAQ · Health Care

Lucid Diagnostics Inc

$1.15
+0.00 (+0.00%)
As of Apr 1, 10:07 PM ET ·
Financial Highlights (FY 2026)
Revenue
11.58M
Net Income
-121,324,314
Gross Margin
-63.3%
Profit Margin
-1,047.6%
Rev Growth
+105.6%
D/E Ratio
3.45
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -63.3% 56.6% 56.6% 56.6%
Operating Margin -1,178.5% 10.2% 10.4% 11.2%
Profit Margin -1,047.6% 8.8% 9.2% 7.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 11.58M 22.63M 23.02M 23.61M
Gross Profit -7,333,706 12.81M 13.04M 13.37M
Operating Income -136,432,407 2.31M 2.39M 2.63M
Net Income -121,324,314 2.00M 2.12M 1.81M
Gross Margin -63.3% 56.6% 56.6% 56.6%
Operating Margin -1,178.5% 10.2% 10.4% 11.2%
Profit Margin -1,047.6% 8.8% 9.2% 7.7%
Rev Growth +105.6% -3.2% +10.8% -8.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 58.44M 56.69M 59.72M 60.47M
Total Equity 16.94M 97.39M 100.69M 99.13M
D/E Ratio 3.45 0.58 0.59 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -118,995,555 3.43M 3.56M 3.69M
Free Cash Flow 1.33M 1.38M 1.42M